Indiana AG Rokita Files Challenge to Block DEA Marijuana Rescheduling

Rokita Challenges DEA Rule in Federal Court

Indiana Attorney General Todd Rokita filed a formal petition on May 29 asking a federal court to halt the DEA's marijuana rescheduling process. The action targets the agency's notice of proposed rulemaking published in 2024 that would move cannabis from Schedule I—reserved for substances with no accepted medical use—to Schedule III, which includes drugs like ketamine and anabolic steroids. Rokita's office didn't specify which federal district court received the filing.

The petition argues the DEA exceeded its statutory authority under the Controlled Substances Act and failed to follow proper administrative procedures. According to Rokita, the rescheduling decision conflicts with the five-factor analysis Congress mandated for controlled substance scheduling, which requires evaluation of abuse potential, scientific evidence of pharmacological effect, current scientific knowledge, history and pattern of abuse, and risk to public health.

Multistate Coalition Mounts Coordinated Opposition

Rokita's filing is part of a broader coalition of Republican state attorneys general opposing the federal policy shift. At least twelve states have signaled intent to challenge the rescheduling through litigation or formal comment submissions during the DEA's public comment period, which closed in July 2024. The coalition includes attorneys general from Nebraska, Kansas, Oklahoma, and South Dakota—all states that maintain full cannabis prohibition at the state level.

This coordinated strategy mirrors opposition tactics used against other federal drug policy changes in recent years. States opposing rescheduling argue the change would undermine their enforcement priorities. It would also create conflicts with existing state criminal statutes that rely on the federal Schedule I classification to define marijuana offenses.

DEA Rule Faces Final Administrative Hurdles

The DEA hasn't yet published a final rule implementing the Schedule III reclassification. The timeline remains uncertain. After reviewing more than 43,000 public comments submitted during the notice-and-comment period, the agency must issue a final rule that addresses substantive objections and provides a reasoned explanation for its decision. Administrative law experts estimate the final rule could be published between June and September 2026, with an effective date 30 to 60 days after publication.

If Rokita's petition succeeds in obtaining a preliminary injunction, it would freeze the rescheduling process until a court rules on the merits of the challenge. Federal courts have granted similar injunctions in past Administrative Procedure Act cases when petitioners demonstrated likelihood of success on the merits and irreparable harm. The DEA declined to comment on pending litigation.

Tax and Regulatory Implications Drive Industry Attention

The rescheduling decision carries immediate financial consequences for state-licensed cannabis operators subject to Internal Revenue Code Section 280E. That provision prohibits businesses trafficking in Schedule I or II controlled substances from deducting ordinary business expenses on federal tax returns. Moving marijuana to Schedule III would eliminate the 280E restriction, reducing effective tax rates for multistate operators from 70 percent to approximately 25 percent and freeing an estimated $1.8 billion annually in currently non-deductible expenses.

Industry analysts project the tax relief would accelerate consolidation in the cannabis sector by improving cash flow for acquisition activity and debt service. Publicly traded MSOs including Curaleaf Holdings, Green Thumb Industries, and Trulieve Cannabis have disclosed in SEC filings that 280E relief is a material factor in long-term profitability projections. Any court-ordered delay in rescheduling would postpone those financial benefits indefinitely.

Indiana Maintains Full Cannabis Prohibition

Indiana remains one of fourteen states with no legal cannabis program of any kind. Criminal penalties apply to possession, cultivation, and distribution. Possession of any amount is a Class B misdemeanor punishable by up to 180 days in jail and a $1,000 fine. Rokita has consistently opposed cannabis liberalization at both state and federal levels, testifying against legalization bills in the Indiana General Assembly in 2023 and 2024.

The attorney general's office stated the federal rescheduling would "create confusion" for Indiana law enforcement and prosecutors who rely on the Schedule I classification in charging decisions and sentencing recommendations. Indiana law doesn't automatically incorporate changes to federal drug schedules, meaning marijuana would remain a Schedule I substance under state statute even if the DEA reclassifies it federally. For full background on the administrative process and timeline, see the CannIntel topic hub on DEA rescheduling.

The next procedural milestone is the DEA's response deadline to Rokita's petition, typically 30 days from filing. If the court schedules oral argument on a preliminary injunction motion, that hearing would likely occur within 60 to 90 days. A final ruling on the merits could take twelve to eighteen months, though the case could be appealed to a federal circuit court regardless of outcome.